The impact of high dose oral cotrimoxazole in patients with COVID-19 with hypoxic respiratory failure requiring non-invasive ventilation: A Case Control Study

Saurabh Singh, Thomas John, Prashant Kumar, Syed Rehan Quadery
doi: https://doi.org/10.1101/2021.01.14.21249803

Article Information

doi 
https://doi.org/10.1101/2021.01.14.21249803
History 
  • January 15, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Saurabh Singh1,*,
  2. Thomas John2,
  3. Prashant Kumar1 and
  4. Syed Rehan Quadery3
  1. 1Department of Respiratory Medicine, IQ City Medical College Hospital, Durgapur, West Bengal, India
  2. 2Department of Acute Medicine, Epsom and St Helier University Hospitals NHS Trust, London, UK
  3. 3Department of Respiratory Medicine, Epsom and St Helier University Hospitals NHS Trust, London, UK
  1. ↵*Corresponding Author: Saurabh Singh, Assistant Professor, Department of Respiratory Medicine, IQ City Medical College Hospital, Durgapur, West Bengal, India. Email: saurabh.singh3108{at}icloud.com
Back to top
Posted January 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email
The impact of high dose oral cotrimoxazole in patients with COVID-19 with hypoxic respiratory failure requiring non-invasive ventilation: A Case Control Study
Saurabh Singh, Thomas John, Prashant Kumar, Syed Rehan Quadery
medRxiv 2021.01.14.21249803; doi: https://doi.org/10.1101/2021.01.14.21249803
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area